Physician profile
Michael J Baum
NPI 1376694786
$1,069.82
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $159 · 2021: $220 · 2022: $213 · 2023: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $244.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $249.07 | 2019-2023 | Breztri |
| Welch Allyn | $220.07 | 2021 | |
| Lilly USA, LLC | $180.43 | 2019-2023 | Mounjaro, Trulicity, Jardiance |
| Novo Nordisk INC | $85.96 | 2020-2023 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $84.60 | 2019-2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $65.32 | 2019-2020 | |
| Exact Sciences Corporation | $61.14 | 2023 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $38.49 | 2019-2020 | |
| Abbott Laboratories | $24.45 | 2023 | Freestyle Libre 2 |
| Teva Pharmaceuticals USA, INC. | $16.37 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.00 | 2019 | |
| Horizon Therapeutics Plc | $14.92 | 2019 | |
| Optinose US, INC. | $14.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Baum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.